| Development and validation of a robust ferroptosis-related prognostic signature in lung adenocarcinoma A Zhang, J Yang, C Ma, F Li, H Luo Frontiers in Cell and Developmental Biology 9, 616271, 2021 | 68 | 2021 |
| Heart failure with preserved ejection fraction: an update on pathophysiology, diagnosis, treatment, and prognosis C Ma, H Luo, L Fan, X Liu, C Gao Brazilian journal of medical and biological research 53, e9646, 2020 | 51 | 2020 |
| A novel ferroptosis-associated gene signature to predict prognosis in patients with uveal melanoma H Luo, C Ma Diagnostics 11 (2), 219, 2021 | 50 | 2021 |
| Identification of a novel tumor microenvironment–associated eight-gene signature for prognosis prediction in lung adenocarcinoma C Ma, H Luo, J Cao, X Zheng, J Zhang, Y Zhang, Z Fu Frontiers in molecular biosciences 7, 571641, 2020 | 44 | 2020 |
| Identification of the differential expression of genes and upstream microRNAs in small cell lung cancer compared with normal lung based on bioinformatics analysis X Li, C Ma, H Luo, J Zhang, J Wang, H Guo Medicine 99 (11), e19086, 2020 | 35 | 2020 |
| Independent prognostic implications of RRM2 in lung adenocarcinoma C Ma, H Luo, J Cao, C Gao, X Fa, G Wang Journal of Cancer 11 (23), 7009, 2020 | 35 | 2020 |
| Identification of prognostic genes in uveal melanoma microenvironment H Luo, C Ma PLoS One 15 (11), e0242263, 2020 | 32 | 2020 |
| Prognostic implications of novel ten-gene signature in uveal melanoma H Luo, C Ma, J Shao, J Cao Frontiers in Oncology 10, 567512, 2020 | 31 | 2020 |
| Independent prognostic potential of GNPNAT1 in lung adenocarcinoma X Zheng, Y Li, C Ma, J Zhang, Y Zhang, Z Fu, H Luo BioMed Research International 2020, 2020 | 23 | 2020 |
| RETRACTED: Astragalus polysaccharide ameliorates lipopolysaccharide-induced cell injury in ATDC5 cells via miR-92a/KLF4 mediation L Fan, M Li, F Cao, Z Zeng, X Li, C Ma, J Ru, X Wu Biomedicine & Pharmacotherapy 118, 109180, 2019 | 20 | 2019 |
| MicroRNA-152 suppresses human osteosarcoma cell proliferation and invasion by targeting E2F transcription factor 3 C Ma, J Han, D Dong, N Wang Oncology research 26 (5), 765, 2018 | 19 | 2018 |
| Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma C Ma, F Li, H Luo Annals of Translational Medicine 9 (13), 2021 | 18 | 2021 |
| Identification of a novel prognostic gene signature from the immune cell infiltration landscape of osteosarcoma L Fan, J Ru, T Liu, C Ma Frontiers in Cell and Developmental Biology 9, 718624, 2021 | 17 | 2021 |
| Long noncoding RNA s: A new player in the prevention and treatment of diabetic cardiomyopathy? C Ma, H Luo, B Liu, F Li, C Tschöpe, X Fa Diabetes/Metabolism Research and Reviews 34 (8), e3056, 2018 | 17 | 2018 |
| Construction and validation of a novel gene signature for predicting the prognosis of osteosarcoma J Yang, A Zhang, H Luo, C Ma Scientific Reports 12 (1), 1279, 2022 | 15 | 2022 |
| A novel immune-related gene signature predicts prognosis of lung adenocarcinoma C Ma, F Li, Z Wang, H Luo BioMed Research International 2022, 2022 | 10 | 2022 |
| Bioinformatic identification of neuroblastoma microenvironment-associated biomarkers with prognostic value Y Wang, H Luo, J Cao, C Ma Journal of Oncology 2020, 2020 | 9 | 2020 |
| Correlation between thymus radiology and myasthenia gravis in clinical practice H Luo, S Xie, C Ma, W Zhang, C Tschöpe, X Fa, J Cheng, J Cao Frontiers in neurology 9, 1173, 2019 | 9 | 2019 |
| Prognosis and personalized treatment prediction in lung adenocarcinoma: An in silico and in vitro strategy adopting cuproptosis related lncRNA towards precision oncology C Ma, F Li, Z He, S Zhao, Y Yang, Z Gu Frontiers in pharmacology 14, 1113808, 2023 | 8 | 2023 |
| Prognostic implications of immune-related eight-gene signature in pediatric brain tumors Y Wang, C Zhou, H Luo, J Cao, C Ma, L Cheng, Y Yang Brazilian Journal of Medical and Biological Research 54, e10612, 2021 | 8 | 2021 |
Tschope cGerman Heart Center at Charité (DHZC) and Institute of Health (BIH/ BCRT ) at Charite , BerlinVerified email at dhzc-charite.de
